{"pmid":32392591,"title":"Co-infection of SARS CoV-2 and influenza A in a Pediatric Patient in Germany.","text":["Co-infection of SARS CoV-2 and influenza A in a Pediatric Patient in Germany.","In December 2019 a novel coronavirus was firstly encountered in Wuhan/China with a massive outbreak of fatal pneumonia leading to a pandemic declared by the World Health Organization in March 2020 (WHO Dashboard COVID-19. [WHO web site]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019), affecting mainly elderly adults with underlying co-morbidities. Clinical course in children below the age of 10 years is considered to be mild or even with subclinical signs (Sinha IP, Ha et al. The Lancet Respiratory medicine 2020;27;S2213-2600(20) 30152-1). We describe a 4 month old infant with co-infection of SARS CoV-2 and influenza A virus.","Klin Padiatr","Wehl, Goetz","Laible, Monika","Rauchenzauner, Markus","32392591"],"abstract":["In December 2019 a novel coronavirus was firstly encountered in Wuhan/China with a massive outbreak of fatal pneumonia leading to a pandemic declared by the World Health Organization in March 2020 (WHO Dashboard COVID-19. [WHO web site]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019), affecting mainly elderly adults with underlying co-morbidities. Clinical course in children below the age of 10 years is considered to be mild or even with subclinical signs (Sinha IP, Ha et al. The Lancet Respiratory medicine 2020;27;S2213-2600(20) 30152-1). We describe a 4 month old infant with co-infection of SARS CoV-2 and influenza A virus."],"journal":"Klin Padiatr","authors":["Wehl, Goetz","Laible, Monika","Rauchenzauner, Markus"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32392591","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1055/a-1163-7385","locations":["Wuhan","China","Germany"],"countries":["China","Germany"],"countries_codes":["CHN|China","DEU|Germany"],"topics":["Case Report"],"weight":1,"_version_":1666528579926622208,"score":9.490897,"similar":[{"pmid":32399452,"pmcid":"PMC7213830","title":"Co-infection with Influenza A and COVID-19.","text":["Co-infection with Influenza A and COVID-19.","COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection. LEARNING POINTS: COVID-19 can co-occur with other viral infections.Some of these co-infections have active treatments, while supportive treatment is the mainstay of treatment for others.","Eur J Case Rep Intern Med","Konala, Venu Madhav","Adapa, Sreedhar","Gayam, Vijay","Naramala, Srikanth","Daggubati, Subba Rao","Kammari, Chetan Brahma","Chenna, Avantika","32399452"],"abstract":["COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection. LEARNING POINTS: COVID-19 can co-occur with other viral infections.Some of these co-infections have active treatments, while supportive treatment is the mainstay of treatment for others."],"journal":"Eur J Case Rep Intern Med","authors":["Konala, Venu Madhav","Adapa, Sreedhar","Gayam, Vijay","Naramala, Srikanth","Daggubati, Subba Rao","Kammari, Chetan Brahma","Chenna, Avantika"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399452","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001656","keywords":["covid-19","coronavirus","acute respiratory distress syndrome","influenza"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666865855053430784,"score":202.00539},{"pmid":32368495,"pmcid":"PMC7184249","title":"Co-infection with SARS-CoV-2 and influenza A virus.","text":["Co-infection with SARS-CoV-2 and influenza A virus.","Coronavirus Disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is spreading globally and poses a major public health threat. We reported a case of influenza A virus and SARS-CoV-2 co-infection. As the number of COVID-19 cases increase, it will be necessary to comprehensively evaluate imaging and other clinical findings as well as consider co-infection with other respiratory viruses.","IDCases","Azekawa, Shuhei","Namkoong, Ho","Mitamura, Keiko","Kawaoka, Yoshihiro","Saito, Fumitake","32368495"],"abstract":["Coronavirus Disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is spreading globally and poses a major public health threat. We reported a case of influenza A virus and SARS-CoV-2 co-infection. As the number of COVID-19 cases increase, it will be necessary to comprehensively evaluate imaging and other clinical findings as well as consider co-infection with other respiratory viruses."],"journal":"IDCases","authors":["Azekawa, Shuhei","Namkoong, Ho","Mitamura, Keiko","Kawaoka, Yoshihiro","Saito, Fumitake"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32368495","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.idcr.2020.e00775","keywords":["covid-19","co-infection","influenza","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138496120651776,"score":159.06082},{"pmid":32371192,"title":"Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus.","text":["Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus.","BACKGROUND: The differential diagnosis between novel coronavirus pneumonia patients (NCPP) and influenza patients (IP) remains a challenge in clinical practice. METHODS: Between January 2018 and March 2020, 1027 NCPP and 1140 IP were recruited from Tongji hospital. Blood routine examination, biochemical indicators, and coagulation function analysis were performed in all participants simultaneously. RESULTS: There was no sex predominance in NCPP. The NCPP were frequently encountered in the sixth and seventh decades of life. The mean age of NCPP (56+/-16 years) was higher than IP (47+/-17 years), but without statistical difference. Although most results of routine laboratory tests between NCPP and IP had no significant difference, some laboratory tests showed an obvious change in NCPP. We observed that NCPP had significantly decreased white blood cells, alkaline phosphatase, and d-dimer, compared with IP. However, the results of lactate dehydrogenase, erythrocyte sedimentation rate and fibrinogen were significantly increased in NCPP compared with those in IP. The diagnostic model based on combination of eighteen routine laboratory indicators showed an area under the curve of 0.796 (95% CI, 0.777 to 0.814), with a sensitivity of 46.93% and a specificity of 90.09% when using a cutoff value of 0.598. CONCLUSIONS: Some routine laboratory results had statistical difference between NCPP and IP. A diagnostic model based on combination of routine laboratory results provides an adjunct approach in the differential diagnosis between NCPP and IP.","Int J Infect Dis","Luo, Ying","Yuan, Xu","Xue, Ying","Mao, Liyan","Lin, Qun","Tang, Guoxing","Song, Huijuan","Liu, Weiyong","Hou, Hongyan","Wang, Feng","Sun, Ziyong","32371192"],"abstract":["BACKGROUND: The differential diagnosis between novel coronavirus pneumonia patients (NCPP) and influenza patients (IP) remains a challenge in clinical practice. METHODS: Between January 2018 and March 2020, 1027 NCPP and 1140 IP were recruited from Tongji hospital. Blood routine examination, biochemical indicators, and coagulation function analysis were performed in all participants simultaneously. RESULTS: There was no sex predominance in NCPP. The NCPP were frequently encountered in the sixth and seventh decades of life. The mean age of NCPP (56+/-16 years) was higher than IP (47+/-17 years), but without statistical difference. Although most results of routine laboratory tests between NCPP and IP had no significant difference, some laboratory tests showed an obvious change in NCPP. We observed that NCPP had significantly decreased white blood cells, alkaline phosphatase, and d-dimer, compared with IP. However, the results of lactate dehydrogenase, erythrocyte sedimentation rate and fibrinogen were significantly increased in NCPP compared with those in IP. The diagnostic model based on combination of eighteen routine laboratory indicators showed an area under the curve of 0.796 (95% CI, 0.777 to 0.814), with a sensitivity of 46.93% and a specificity of 90.09% when using a cutoff value of 0.598. CONCLUSIONS: Some routine laboratory results had statistical difference between NCPP and IP. A diagnostic model based on combination of routine laboratory results provides an adjunct approach in the differential diagnosis between NCPP and IP."],"journal":"Int J Infect Dis","authors":["Luo, Ying","Yuan, Xu","Xue, Ying","Mao, Liyan","Lin, Qun","Tang, Guoxing","Song, Huijuan","Liu, Weiyong","Hou, Hongyan","Wang, Feng","Sun, Ziyong"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371192","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ijid.2020.04.078","keywords":["influenza patients","influenza virus","laboratory tests","novel coronavirus pneumonia patients","sars-cov-2"],"locations":["Tongji","NCPP"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496503382016,"score":157.4643},{"pmid":32347975,"title":"HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.","text":["HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.","In December 2019, the causative agent of Coronavirus disease 2019 (COVID-19) was identified and named as SARS-CoV-2. Since then it has been spreading and severe form of the illness predominantly occurs in adults with advanced age or underlying comorbidities. The European AIDS Clinical Society states the lack of evidence for a higher COVID-19 infection rate among people living with HIV (PLHIV) and there is a few published literature on the course of COVID-19 co-infection in PLHIV. We described four HIV/SARS-CoV-2 co-infected patients with different characteristics. The impression is that comorbidities is an important factor in mortality in HIV/SARS-CoV-2 co-infected cases. This article is protected by copyright. All rights reserved.","J Med Virol","Altuntas Aydin, Ozlem","Kumbasar Karaosmanoglu, Hayat","Kart Yasar, Kadriye","32347975"],"abstract":["In December 2019, the causative agent of Coronavirus disease 2019 (COVID-19) was identified and named as SARS-CoV-2. Since then it has been spreading and severe form of the illness predominantly occurs in adults with advanced age or underlying comorbidities. The European AIDS Clinical Society states the lack of evidence for a higher COVID-19 infection rate among people living with HIV (PLHIV) and there is a few published literature on the course of COVID-19 co-infection in PLHIV. We described four HIV/SARS-CoV-2 co-infected patients with different characteristics. The impression is that comorbidities is an important factor in mortality in HIV/SARS-CoV-2 co-infected cases. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Altuntas Aydin, Ozlem","Kumbasar Karaosmanoglu, Hayat","Kart Yasar, Kadriye"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347975","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/jmv.25955","keywords":["hiv","sars-cov-2","co-infection"],"locations":["Istanbul","Turkey"],"countries":["Turkey"],"countries_codes":["TUR|Turkey"],"topics":["Case Report"],"weight":1,"_version_":1666138494930518016,"score":156.90198},{"pmid":32475878,"title":"The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.","text":["The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.","Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, three children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the three cases experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered.","Jpn J Infect Dis","Kakuya, Fujio","Okubo, Hitoshi","Fujiyasu, Hiroaki","Wakabayashi, Iori","Syouji, Masayo","Kinebuchi, Takahiro","32475878"],"abstract":["Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, three children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the three cases experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered."],"journal":"Jpn J Infect Dis","authors":["Kakuya, Fujio","Okubo, Hitoshi","Fujiyasu, Hiroaki","Wakabayashi, Iori","Syouji, Masayo","Kinebuchi, Takahiro"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475878","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7883/yoken.JJID.2020.181","keywords":["covid-19","sars-cov-2","children","co-infection","respiratory pathogens"],"locations":["Wuhan","China","Japan","Hokkaido","Furano","Hokkaido","Japan","Furano","Japan","Japan"],"countries":["Japan","China"],"countries_codes":["JPN|Japan","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668437835071356928,"score":156.0231}]}